Key Points
It missed, although not badly, the analyst consensus estimates on both the top and bottom lines in its latest reported quarter.
That probably wasn't the main reason for the concentrated investor sell-off, however.
Genesco (NYSE: GCO) published its third quarter of fiscal 2026 earnings report Thursday morning, and it probably wishes it hadn't. The footwear retailer missed consensus analyst estimates for revenue and profitability, further compounded by reductions to its guidance. Investors punished the company by aggressively selling their shares, causing the stock price to fall by almost 31% that day.
Voting with their feet
During the quarter, Genesco reported net sales of $616 million, representing a 3% year-over-year increase. That was on the back of comparable sales that increased at the same rate. Net income not in accordance with generally accepted accounting principles (GAAP) rose more robustly, advancing by 27% to $8.4 million, or $0.79 per share.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
Despite the gains, neither metric reached its respective average analyst estimate. Pundits tracking Genesco stock were modeling more than $618 million in net sales and $0.88 per share for non-GAAP (adjusted) net income.
In the earnings release, Genesco touted the strength of its leading retail brand.
It quoted CEO Mimi Vaughn as saying that "This performance reinforces that when consumers shop for footwear, they are increasingly choosing Journeys, underscoring the momentum of our product elevation and diversification strategy as we continue to gain market share and establish ourselves as the destination for the style-led teen."
That's one deep cut
That might be accurate, but Genesco's downward adjustment to full-year 2026 guidance suggests it isn't fully confident about the future. The company now expects sales to increase by 2% over the fiscal 2025 total, driven by a comparable sales growth of 3%. Previously, it was guiding for 3% to 4% for the former metric, and 5% for the latter.
Earnings guidance was also reduced, as Genesco set a new expectation for adjusted net income of $0.95 per share for the year. That's down significantly from the preceding range of $1.30 to $1.70.
Although the company's stock probably didn't deserve such a concentrated sell-off following these results, the chop in bottom-line guidance is definitely worrying. It's understandable that investors are choosing to avoid the company for now.
Should you invest $1,000 in Genesco right now?
Before you buy stock in Genesco, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Genesco wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $560,649!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,100,862!*
Now, it’s worth noting Stock Advisor’s total average return is 998% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of December 1, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.